BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank21
3Y CAGR-12.0%
5Y CAGR-18.0%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-12.0%/yr
vs -22.2%/yr prior
5Y CAGR
-18.0%/yr
Recent acceleration
Acceleration
+10.3pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.90M | -14.0% |
| 2024 | $12.67M | -26.9% |
| 2023 | $17.34M | +8.5% |
| 2022 | $15.97M | +4.1% |
| 2021 | $15.34M | -47.7% |
| 2020 | $29.31M | +24.9% |
| 2019 | $23.46M | -46.3% |
| 2018 | $43.66M | +2.2% |
| 2017 | $42.71M | +8.1% |
| 2016 | $39.50M | - |